Prof. Dr. Dr. Flavio Forrer
chief of service
Radiologie und Nuklearmedizin · Dept. IV
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
Giammarile F, Luster M, Tennvall J, Borson-Chazot F, Konijnenberg M, Lambert B, Brans B, Kraeber-Bodere F, Forrer F, Flux G, Chiesa C, Bodei L, Therapy, Oncology and Dosimetry Committees. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging 2011; 38:1393-406.
Jul 1, 2011EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
Jul 1, 2011Eur J Nucl Med Mol Imaging 2011; 38:1393-406
Giammarile Francesco, Luster Markus, Tennvall Jan, Borson-Chazot Françoise, Konijnenberg Mark, Lambert Bieke, Brans Boudewijn, Kraeber-Bodere Françoise, Forrer Flavio, Flux Glenn, Chiesa Carlo, Bodei Lisa, Therapy, Oncology and Dosimetry Committees
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
Wild D, Ell P, Perren A, Bomanji J, Weber W, Seufert J, Brändle M, Forrer F, Kurzawinski T, Caplin M, Christ E, Reubi J. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011; 52:1073-8.
Jun 16, 2011Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
Jun 16, 2011J Nucl Med 2011; 52:1073-8
Wild Damian, Ell Peter J, Perren Aurel, Bomanji Jamshed, Weber Wolfgang A, Seufert Jochen, Brändle Michael, Forrer Flavio, Kurzawinski Tom R, Caplin Martyn E, Christ Emanuel, Reubi Jean Claude
Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy
Giovacchini G, Nicolas G, Freidank H, Mindt T, Forrer F. Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy. Eur J Nucl Med Mol Imaging 2011; 38:1675-82.
May 7, 2011Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy
May 7, 2011Eur J Nucl Med Mol Imaging 2011; 38:1675-82
Giovacchini Giampiero, Nicolas Guillaume, Freidank Heike, Mindt Thomas L, Forrer Flavio
Targeted radiotherapy with radiolabeled somatostatin analogs
Nicolas G, Giovacchini G, Müller-Brand J, Forrer F. Targeted radiotherapy with radiolabeled somatostatin analogs. Endocrinol Metab Clin North Am 2011; 40:187-204, ix-x.
Mar 1, 2011Targeted radiotherapy with radiolabeled somatostatin analogs
Mar 1, 2011Endocrinol Metab Clin North Am 2011; 40:187-204, ix-x
Nicolas Guillaume, Giovacchini Giampiero, Müller-Brand Jan, Forrer Flavio
Sentinel lymph node biopsy in primary breast cancer: trust the radiolabeled colloid method and avoid unnecessary procedures
Schmid S, Myrick M, Forrer F, Obermann E, Viehl C, Rochlitz C, Güth U. Sentinel lymph node biopsy in primary breast cancer: trust the radiolabeled colloid method and avoid unnecessary procedures. Eur J Surg Oncol 2011; 37:211-6.
Jan 19, 2011Sentinel lymph node biopsy in primary breast cancer: trust the radiolabeled colloid method and avoid unnecessary procedures
Jan 19, 2011Eur J Surg Oncol 2011; 37:211-6
Schmid S M, Myrick M E, Forrer Flavio, Obermann E C, Viehl C T, Rochlitz C, Güth U
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Mansi R, Wang X, Forrer F, Waser B, Cescato R, Graham K, Borkowski S, Reubi J, Maecke H. Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours. Eur J Nucl Med Mol Imaging 2010; 38:97-107.
Aug 18, 2010Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Aug 18, 2010Eur J Nucl Med Mol Imaging 2010; 38:97-107
Mansi Rosalba, Wang Xuejuan, Forrer Flavio, Waser Beatrice, Cescato Renzo, Graham Keith, Borkowski Sandra, Reubi Jean Claude, Maecke Helmut R
Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P--results from a phase I study
Cordier D, Forrer F, Kneifel S, Sailer M, Mariani L, Mäcke H, Müller-Brand J, Merlo A. Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P--results from a phase I study. J Neurooncol 2010; 100:129-36.
Mar 10, 2010Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P--results from a phase I study
Mar 10, 2010J Neurooncol 2010; 100:129-36
Cordier Dominik, Forrer Flavio, Kneifel Stefan, Sailer Martin, Mariani Luigi, Mäcke Helmut, Müller-Brand Jan, Merlo Adrian
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
Cordier D, Reubi J, Mäcke H, Müller-Brand J, Good S, Apostolidis C, Morgenstern A, Bruchertseifer F, Forrer F, Merlo A. Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial. Eur J Nucl Med Mol Imaging 2010; 37:1335-44.
Feb 16, 2010Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
Feb 16, 2010Eur J Nucl Med Mol Imaging 2010; 37:1335-44
Cordier D, Reubi J C, Mäcke H, Müller-Brand J, Good S, Apostolidis C, Morgenstern A, Bruchertseifer F, Forrer Flavio, Merlo A
Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours
Abiraj K, Mansi R, Tamma M, Forrer F, Cescato R, Reubi J, Akyel K, Maecke H. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours. Chemistry 2010; 16:2115-24.
Feb 15, 2010Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours
Feb 15, 2010Chemistry 2010; 16:2115-24
Abiraj Keelara, Mansi Rosalba, Tamma Maria-Luisa, Forrer Flavio, Cescato Renzo, Reubi Jean Claude, Akyel Kayhan G, Maecke Helmut R
Glucagon-like peptide-1 receptor imaging for localization of insulinomas
Christ E, Maecke H, Martius F, Gloor B, Clerici T, Sahli R, Brändle M, Forrer F, Wild D, Reubi J. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. The Journal of clinical endocrinology and metabolism 2009; 94:4398-405.
Nov 1, 2009Glucagon-like peptide-1 receptor imaging for localization of insulinomas
Nov 1, 2009The Journal of clinical endocrinology and metabolism 2009; 94:4398-405
Christ Emanuel, Maecke Helmut, Martius Ferdinand, Gloor Beat, Clerici Thomas, Sahli Rahel, Brändle Michael, Forrer Flavio, Wild Damian, Reubi Jean Claude
Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice
Mitchell J, Hoeijmakers J, IJzermans J, van IJcken W, de Jong M, Müller C, Forrer F, Chu T, van den Engel S, Goemaere N, van de Ven M, Brand K, Verweij M, de Bruin R. Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice. Aging Cell 2009; 9:40-53.
Oct 30, 2009Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice
Oct 30, 2009Aging Cell 2009; 9:40-53
Mitchell James R, Hoeijmakers Jan H J, IJzermans Jan N M, van IJcken Wilfred, de Jong Marion, Müller Cristina, Forrer Flavio, Chu Timothy, van den Engel Sandra, Goemaere Natascha, van de Ven Marieke, Brand Karl, Verweij Mariëlle, de Bruin Ron W F
Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients
Erlic Z, Fottner C, Forrer F, Plöckinger U, Petersenn S, Zabolotny D, Kollukch O, Yaremchuk S, Januszewicz A, Walz M, Eng C, Neumann H, Klose S, Opocher G, Rybicki L, Peçzkowska M, Golcher H, Kann P, Brauckhoff M, Müssig K, Muresan M, Schäffler A, Reisch N, Schott M, Fassnacht M, European-American Pheochromocytoma Study Group. Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Clin Cancer Res 2009; 15:6378-85.
Oct 13, 2009Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients
Oct 13, 2009Clin Cancer Res 2009; 15:6378-85
Erlic Zoran, Fottner Christian, Forrer Flavio, Plöckinger Ursula, Petersenn Stephan, Zabolotny Dimitry, Kollukch Oleg, Yaremchuk Svetlana, Januszewicz Andrzej, Walz Martin K, Eng Charis, Neumann Hartmut P H, Klose Silke, Opocher Giuseppe, Rybicki Lisa, Peçzkowska Mariola, Golcher Henriette, Kann Peter H, Brauckhoff Michael, Müssig Karsten, Muresan Michaela, Schäffler Andreas, Reisch Nicole, Schott Matthias, Fassnacht Martin, European-American Pheochromocytoma Study Group
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides
Mansi R, Wang X, Forrer F, Kneifel S, Tamma M, Waser B, Cescato R, Reubi J, Maecke H. Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides. Clin Cancer Res 2009; 15:5240-9.
Aug 11, 2009Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides
Aug 11, 2009Clin Cancer Res 2009; 15:5240-9
Mansi Rosalba, Wang Xuejuan, Forrer Flavio, Kneifel Stefan, Tamma Maria-Luisa, Waser Beatrice, Cescato Renzo, Reubi Jean Claude, Maecke Helmut R
In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study
Forrer F, Chen J, Fani M, Powell P, Lohri A, Müller-Brand J, Moldenhauer G, Maecke H. In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study. Eur J Nucl Med Mol Imaging 2009; 36:1443-52.
Apr 7, 2009In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study
Apr 7, 2009Eur J Nucl Med Mol Imaging 2009; 36:1443-52
Forrer Flavio, Chen Jianhua, Fani Melpomeni, Powell Pia, Lohri Andreas, Müller-Brand Jan, Moldenhauer Gerhard, Maecke Helmut R
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate
Forrer F, de Herder W, van Lom K, de Jong M, Teunissen J, Bakker W, Konijnenberg M, Bernard B, Kooij P, Krenning E, Kwekkeboom D. Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate. Eur J Nucl Med Mol Imaging 2009; 36:1138-46.
Feb 27, 2009Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate
Feb 27, 2009Eur J Nucl Med Mol Imaging 2009; 36:1138-46
Forrer Flavio, de Herder Wouter W, van Lom Kirsten, de Jong Marion, Teunissen Jaap J M, Bakker Willem H, Konijnenberg Mark, Bernard Bert F, Kooij Peter P, Krenning Eric P, Kwekkeboom Dik J
Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues
Muros M, Varsavsky M, Iglesias Rozas P, Valdivia J, Delgado J, Forrer F, Bodei L, Paganelli G. Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues. Clin Transl Oncol 2009; 11:48-53.
Jan 1, 2009Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues
Jan 1, 2009Clin Transl Oncol 2009; 11:48-53
Muros M A, Varsavsky M, Iglesias Rozas P, Valdivia J, Delgado J R, Forrer Flavio, Bodei L, Paganelli G
Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma
Forrer F, Riedweg I, Maecke H, Mueller-Brand J. Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma. Q J Nucl Med Mol Imaging 2008; 52:334-40.
May 16, 2008Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma
May 16, 2008Q J Nucl Med Mol Imaging 2008; 52:334-40
Forrer Flavio, Riedweg I, Maecke H R, Mueller-Brand J
SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate
Müller C, Forrer F, Schibli R, Krenning E, de Jong M. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate. J Nucl Med 2008; 49:310-7.
Jan 16, 2008SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate
Jan 16, 2008J Nucl Med 2008; 49:310-7
Müller Cristina, Forrer Flavio, Schibli Roger, Krenning Eric P, de Jong Marion
Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats
Rolleman E, Krenning E, Boerman O, Gotthardt M, Hoppin J, de Blois E, Forrer F, Breeman W, Bernard B, de Jong M. Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats. Nuklearmedizin 2008; 47:110-5.
Jan 1, 2008Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats
Jan 1, 2008Nuklearmedizin 2008; 47:110-5
Rolleman E J, Krenning E P, Boerman O C, Gotthardt M, Hoppin J, de Blois E, Forrer Flavio, Breeman W A P, Bernard B F, de Jong M
Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy
Melis M, Forrer F, Capello A, Bijster M, Bernard B, Reubi J, Krenning E, de Jong M. Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy. Q J Nucl Med Mol Imaging 2007; 51:324-33.
Dec 1, 2007Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy
Dec 1, 2007Q J Nucl Med Mol Imaging 2007; 51:324-33
Melis M, Forrer Flavio, Capello A, Bijster M, Bernard B F, Reubi J C, Krenning E P, de Jong M